Results 141 to 150 of about 21,745 (180)
Some of the next articles are maybe not open access.
Pathology of in-stent restenosis
Current Opinion in Lipidology, 1999The process of in-stent restenosis parallels wound healing responses. Stent deployment results in early thrombus deposition and acute inflammation, granulation tissue development, and ultimately smooth muscle cell proliferation and extracellular matrix synthesis.
R, Virmani, A, Farb
openaire +2 more sources
In-stent Restenosis of drug-eluting Stents
Future Cardiology, 2013Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic ...
Sa'ar, Minha +2 more
openaire +2 more sources
The Journal of Cardiovascular Surgery
Endovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym +5 more
openaire +3 more sources
Endovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym +5 more
openaire +3 more sources
In-stent restenosis in vertebral artery stenting
Neuroradiology, 2007Sir, Tsutsumi et al. reported the clinical and angiographic data on 12 patients receiving stent deployment for symptomatic ostial vertebral artery (VA) stenosis [1]. The in-stent re-stenosis (ISR) rate was surprising low – 0% angiographic restenosis at 12 months and 8% after a mean of 31.5 months clinical/radiological follow-up.
Yen-Hung, Lin, Hsien-Li, Kao
openaire +2 more sources
2018
Restenosis is an arterial wall healing response to mechanical injury at the site of a previously treated coronary segment. In-stent restenosis (ISR) is an angiographic diagnosis, defined as recurrent diameter stenosis >50% within a stent or at its edges (5 mm segments proximal and distal to the stent).
Roisin Colleran, Robert A. Byrne
openaire +1 more source
Restenosis is an arterial wall healing response to mechanical injury at the site of a previously treated coronary segment. In-stent restenosis (ISR) is an angiographic diagnosis, defined as recurrent diameter stenosis >50% within a stent or at its edges (5 mm segments proximal and distal to the stent).
Roisin Colleran, Robert A. Byrne
openaire +1 more source
Italian heart journal : official journal of the Italian Federation of Cardiology, 2001
Even after optimal immediate results, restenosis still occurs in a relevant percentage of patients after stent implantation. This disappointing outcome has strong clinical and socio-economical implications and has become a major target of research in cardiology.
openaire +4 more sources
Even after optimal immediate results, restenosis still occurs in a relevant percentage of patients after stent implantation. This disappointing outcome has strong clinical and socio-economical implications and has become a major target of research in cardiology.
openaire +4 more sources
Late Restenosis Following Placement of a Sirolimus Eluting Stent for In-Stent Restenosis
Heart, Lung and Circulation, 2007Drug eluting stents (DES) are rapidly replacing intravascular brachytherapy for the treatment of bare metal in-stent restenosis (ISR). To date, there are no long-term follow up data supporting this practise. We report symptomatic repeat in-stent restenosis occurring 27 months after sirolimus eluting stent deployment for de novo in-stent restenosis ...
Onn Akbar, Ali +3 more
openaire +2 more sources
Third in‐stent restenosis in sirolimus eluting stents
Catheterization and Cardiovascular Interventions, 2012AbstractObjectives:We evaluated the predictive factors for recurrent restenosis lesions treated on two previous occasions with sirolimus‐eluting stents (SES).Background:Angiography data related to recurrent SES restenosis have not been reported.Methods:Binary restenosis was observed in 66 patients with 78 lesions from a total of 1,393 patients with 1 ...
Makito, Ozawa +10 more
openaire +2 more sources
Carotid brachytherapy for in‐stent restenosis
Catheterization and Cardiovascular Interventions, 2002AbstractCarotid stenting has emerged as an alternative revascularization modality to endarterectomy for the treatment of carotid artery disease. Restenosis of a carotid stent may be occasionally seen. Our experience in intravascular radiation therapy for coronary restenosis has provided us the opportunity to explore this treatment strategy for carotid ...
Albert W, Chan +8 more
openaire +2 more sources
Stenting the stent: Alternative strategy for treating in‐stent restenosis
Catheterization and Cardiovascular Diagnosis, 1996Several approaches have been taken to relieve restenosis inside a vascular stent. In a patient with a complicated history of coronary artery disease, a restenotic lesion inside a Gianturco-Roubin flex stent was relieved by angioplasty and deployment of three 10 mm Palmaz P-104 "biliary" stents, with urokinase and verapamil used to prevent ...
openaire +2 more sources